Role of platelet-derived chemokines (RANTES and ENA-78) after stem cell transplantation

This publication has 34 references indexed in Scilit:

• Serum cytokine levels and acute graft-versus-host disease after HLA-identical hematopoietic stem cell transplantation
  Experimental Hematology, 2003
• Serum stem cell growth factor for monitoring hematopoietic recovery following stem cell transplantation
  Bone Marrow Transplantation, 2003
• Proinflammatory cytokines and their role in the development of major transplant-related complications in the early phase after allogeneic bone marrow transplantation
  Leukemia, 2003
• Active participation of CCR5+CD8+ T lymphocytes in the pathogenesis of liver injury in graft-versus-host disease
  Journal of Clinical Investigation, 1999
• Soluble interleukin-2 receptor serum levels after allogeneic bone marrow transplantation as a marker for GVHD
  Bone Marrow Transplantation, 1998
• The Immunopathophysiology of Acute Graft‐Versus‐Host‐Disease
  The International Journal of Cell Cloning, 1996
• The CXC Chemokines Growth-regulated Oncogene (GRO) α, GROβ, GROγ, Neutrophil-activating Peptide-2, and Epithelial Cell-derived Neutrophil-activating Peptide-78 Are Potent Agonists for the Type B, but Not the Type A, Human Interleukin-8 Receptor
  Journal of Biological Chemistry, 1996
• Chemokine and chemokine receptor mRNA expression in human platelets
  Cytokine, 1995
• Cytokine RANTES released by thrombin-stimulated platelets is a potent attractant for human eosinophils.
  The Journal of Experimental Medicine, 1992
• Human monocyte chemoattractant protein-1 (MCP-1)
  Immunology Today, 1990